文献速递骨肌MR

丛状纤维组织细胞瘤:影像特征与临床表现

Plexiform fibrohistiocytic tumor: imaging features and clinical findings.
PubMed 文献 · Skeletal Radiol · 2018-08-25

本研究回顾性分析了13例病理确诊为丛状纤维组织细胞瘤患者的影像与临床资料,肿瘤多表现为皮下、上肢或头颈部、斑块样或浸润性病变,T1WI与肌肉等信号、液体敏感序列高信号并强化;5例(38%)术后有残留肿瘤,与术后改变难以区分,1例(8%)出现淋巴结和肺转移。

要点

  • 丛状纤维组织细胞瘤常呈斑块样或浸润性生长,可无圆形或卵圆形肿块。
  • 肿瘤多位于皮下,好发于上肢或头颈部,T1WI与肌肉等信号、液体敏感序列高信号并强化。
  • 术后残留肿瘤(38%)可类似术后改变,阅片时需注意鉴别。

核心结论

  • 丛状纤维组织细胞瘤常表现为斑块样或浸润性病变,可无圆形或卵圆形肿块,多位于上肢或头颈部皮下;术后常存在残留肿瘤,且可能与术后改变无法区分。

研究设计与样本

  • 回顾性研究,检索机构数据库纳入病理确诊为丛状纤维组织细胞瘤且具有原发部位影像的患者13例(女8例、男5例,平均年龄15.9岁,范围3-41岁),由两名放射科医生评估原发、残留或复发肿瘤的部位、大小、形态、MR信号特征与强化及邻近结构受累情况,并复习电子病历获取临床资料。

关键影像表现/征象

  • 肿瘤多表现为单发、无痛、质硬、缓慢生长的皮下病变,好发于上肢或头颈部。
  • 多数肿瘤在MRI上呈纯斑块样或浸润性形态,部分未见圆形或卵圆形肿块。
  • 肿瘤在T1加权成像上主要与肌肉等信号,在液体敏感序列上呈高信号,钆对比剂增强后强化。

临床应用与阅片要点

  • 阅片时需注意丛状纤维组织细胞瘤可呈斑块样或浸润性生长而无明确肿块,避免漏诊。
  • 术后影像评估残留肿瘤时,需注意其可与术后改变表现相似而难以区分。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To describe the imaging features of plexiform fibrohistiocytic tumor and its associated clinical findings.

MATERIALS AND METHODS: An institutional database was searched to identify all patients with a pathological diagnosis of plexiform fibrohistiocytic tumor. The electronic medical record was reviewed for relevant clinical data. Radiologic images of the primary tumor site were reviewed by two radiologists to assess primary, residual, or recurrent tumor with respect to tumor location, size, morphology, MR signal characteristics and enhancement, and involvement of adjacent structures.

RESULTS: Thirteen patients with imaging of the primary tumor site were identified [eight female, five male; mean age, 15.9 years (range, 3-41 years)]. Plexiform fibrohistiocytic tumor typically manifested as a solitary, painless, firm, slow-growing lesion centered in the subcutaneous tissues, with a predilection for the upper extremity or head and neck region. Most tumors had a purely plaque-like or infiltrative morphology at MRI; some demonstrated no round or oval mass. Tumors were predominantly isointense to muscle on T1-weighted imaging and hyperintense on fluid-sensitive imaging, and enhanced after gadolinium contrast administration. Five patients (38%) had residual tumor after initial surgery, resembling postoperative changes. No patient had recurrent tumor. One patient (8%) developed metastases to local lymph nodes and to the lung. No patient died from plexiform fibrohistiocytic tumor.

CONCLUSIONS: Plexiform fibrohistiocytic tumor often manifests as a plaque-like or infiltrative process, sometimes without a round or oval mass, most commonly in the subcutaneous tissues of the upper extremity or head and neck region. Residual tumor is often present after initial surgery, and may be indistinguishable from postoperative changes.

来源:Skeletal Radiol,查看原文。版权归原作者所有。

引用

  1. Ghuman M, Hwang S, Antonescu CR, et al. Plexiform fibrohistiocytic tumor: imaging features and clinical findings. Skeletal Radiol. 2018. PMID: 30145610. doi:10.1007/s00256-018-3050-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。